Virus-infected cells are located proximal to conduits. Wild-type VACV and the related, non-replicating strain MVA have been employed extensively to visualize antiviral immunity in the LN.
L Ns, the site of initiation of adaptive immune responses, are highly organized structures optimized for receiving and presenting foreign antigens to naive T and B lymphocytes. Movement of antigen to and within the LN dictates the activation of lymphocytes in ways that are incompletely understood and are poised to impact the magnitude and effectiveness of the immune response. Despite the importance of LN antigen presentation, antigen movement in the LN has primarily been studied at spatial resolution after challenge with non-infectious antigens [1] [2] [3] [4] [5] [6] [7] [8] . Although the list is increasing, only a handful of viruses have been directly visualized in the infected LN, including vaccinia virus (VACV) and modified vaccinia Ankara (MVA) (for examples of studies imaging these viruses, see refs. [9] [10] [11] [12] [13] [14] [15] ).
Virions traffic to the LN within minutes of deposition into peripheral tissues 10 . Virions present in the interstitial fluid flow into a network of unidirectional afferent lymphatic vessels and are transported to the LNs. Conveyed virions are deposited into the LN subcapsular sinus (SCS), a large cavity underneath the LN capsule lined with lymphatic endothelial cells (LECs) and phagocytic SCS macrophages 10, [16] [17] [18] . These macrophages represent the first line of defense against invading pathogens, and in their absence both viruses and bacteria can escape the LN and infect peripheral tissues 11, 17 . Although less numerous than the macrophages, sinus-associated dendritic cells (DCs) also access particulate antigens in LN sinuses 5, 19, 20 . Particulates not acquired by phagocytic cells continue through nodal sinuses before exiting through efferent lymphatics 20 .
Antigen-presenting cells (APCs) within the LN acquire viral antigen via one of several routes defined largely through studies utilizing protein or polysaccharide administration. Although lymphborne proteins are deposited into the SCS, the SCS floor is lined by LECs that prevent free access to the LN paracortex. Low-molecularweight proteins (<70 kDa) can access the LN reticular conduit system that connects the SCS to the paracortex 1, 21 . The conduits consist of a core of organized collagen fibrils ensheathed by fibroblastic reticular cells (FRCs), forming a channel through which small proteins are transported. The conduit system runs throughout the LN but is less dense in the B cell follicles and deep T cell zone 22, 23 .
The conduits are not contiguous, with approximately 10% of the conduit surface having gaps in FRCs covered by DCs 3 . Conduitassociated DCs access luminal contents and can present conduittransported antigens to naive T cells. Although the biophysical properties of the core of collagen fibrils were originally thought to control the size limitation for conduit entry, it was recently shown that the LEC protein plasmalemma vesicle-associated protein (PLVAP) establishes the 70-kDa 'filter' 6 . PLVAP proteins on LECs form structures at conduit entry sites in the SCS thought to prevent anything over 70 kDa from accessing the conduits. In accordance with this, a recent study showed that subcutaneously injected IgM (~150 kDa) was excluded from the conduits; in contrast, IgM injected directly into the LN paracortex could enter the conduit system 8 .
Owing to their large size, virions are not believed to gain entry to the LN paracortex via conduit transport. After subcutaneous injection, VACV virions arrive at the LN within minutes, are deposited into the SCS, and infect a sessile layer of macrophages on the SCS floor 10, 13 . Virions not captured by SCS-resident cells continue through LN sinuses but should be unable to access the LN paracortex. We analyzed virion transport in the LN after infection with VACV and Zika virus (ZIKV). VACV is a large DNA virus that is used both to study antiviral immunity in the draining LN and as a human vaccine vector 24, 25 . ZIKV is a small RNA virus responsible for recent explosive human outbreaks 26 . Here we show that multiple viruses (even VACV, the largest human viral pathogen) can enter LN conduits and infect paracortical DCs, leading to rapid and direct T cell priming in the LN paracortex.
Additionally, both VACV and MVA are currently inoculated into humans, with the latter serving as a vector for recombinant proteins 25 . Many imaging studies and vaccine trials administer 10 8 plaque-forming units (PFU) or more of VACV or MVA (for examples, see refs. 27, 28 ), whereas immunological studies often infect at lower viral doses. It is currently unclear how viral dose affects the spatial organization of T cell priming in the LN, as such spatial analyses have not been systematically compared. Therefore, we carefully quantified the location of VACV-and MVA-infected cells in the draining LN across viral doses ( Fig. 1 ). As previously reported, by using viral-promoter-driven expression of a fluorescent protein (influenza virus nucleoprotein-SIINFEKL-enhanced green fluorescent protein (NP-S-eGFP), a fusion protein with nuclearly localized eGFP along with the SIINFEKL determinant from ovalbumin), we detected robust viral infection of cells in the peripheral SCS and interfollicular area (IFA) within 8 h of infection with either virus 10 (Fig. 1a,b ). Staining for VACV antigen confirmed that eGFP was produced in conjunction with VACV proteins ( Supplementary Fig. 1 ) rather than its expression being acquired by uninfected cells. Unexpectedly, at higher viral doses, we visualized numerous virus-infected cells within the LN paracortex ( Fig. 1a,b and Supplementary Fig. 2 ). We next quantified the location of infected cells in the SCS and IFA region, B cell follicles, T cell zone, and medulla of frozen sections of mouse LNs collected 8 h after footpad injection with 10 8 PFU of VACV or MVA ( Fig. 1c,d ). We classified different LN anatomical regions by staining sections with antibodies against the LN stroma (ERTR7; recognizing reticular fibroblast antigen), the lymphoid sinuses (Lyve-1; recognizing LECs), and B cells (B220) as previously described 18 . Although most infected cells were located in the SCS and IFA region, with the next highest number found in the medullary sinuses, on average ~11% of VACV-infected cells and ~4% of MVA-infected cells were present in the T cell zone ( Fig. 1d ). Higher-magnification images showed VACV-infected cells contacting LECs in the SCS and IFA region and in sinuses ( Fig. 1e , right), but also visualized infected cells in nodal conduits in the T cell zone located distally from apparent LECs (Fig. 1e , left). Quantification of cells touching either conduits or sinuses revealed that approximately 20% of infected cells contacted only conduits; this 20% of infected cells included cells located in the SCS and IFA region as well as in the T cell zone (Fig. 1f ). Collectively, these data demonstrate that infected cells are present in the T cell zone of the LN after infection with 10 8 PFU of VACV and that paracortical infected cells closely associate with conduits.
Paracortical infected cells appear rapidly. To understand how virus-infected cells arrived in the LN paracortex, we next kinetically analyzed LNs after infection with 10 8 PFU of VACV ( Fig. 2 ). By using an antibody against GFP, we detected VACV-infected cells in the SCS and IFA region, T cell zone, and medulla by 1 h after infection ( Fig. 2a ). We continued to observe VACV-infected cells in the T cell zone throughout the next 7 h of infection ( Fig. 2b and Supplementary Fig. 3 ), suggesting that these cells were infected soon after viral inoculation and then remained associated with conduits. On the basis of these data and those from other laboratories 10,13 , we summarize the following timeline of nodal VACV infection after subcutaneous injection: VACV virions arrive in the draining LN within minutes (possibly seconds) of inoculation. Infected cells can be detected in the LN after staining for GFP within an hour of footpad administration of 10 8 PFU of virus. After 4 h, VACVinfected cells can be detected simply by the robust expression of eGFP. Within 12-24 h, VACV-infected SCS macrophages pyroptose as a result of inflammasome activation 13, 14 . Taken together, these data demonstrate that VACV-infected cells can be detected rapidly in the LN paracortex after infection, and detection is enhanced by the accumulation of virally expressed eGFP.
Vaccinia virions are transported by nodal conduits. The presence of infected cells in the T cell zone so quickly after infection led us
to question whether virions could be transported in the LN conduits running from peripheral sinuses. To investigate this possibility, we first conjugated purified VACV to Alexa Fluor 647 dye and extensively purified virions to remove residual dye. By using confocal microscopy, we visualized labeled virions in LN conduits within 3-5 min of viral injection ( Fig. 3a,b ). We next conjugated purified VACV to 10-nm gold particles, injected 10 8 PFU in the footpad, and analyzed LN sections by electron microscopy (EM) 3-5 min after injection. Electron micrographs showed numerous instances of gold-particle-labeled VACV virions within conduits ( Fig. 3c and Supplementary Fig. 4 ). Thus, VACV virions can be accommodated by LN conduits.
In the LN, the protein PLVAP is expressed on LECs in the SCS that line the entrance of conduits 6 as well as on other stromal cell populations. On LECs, this protein forms structures at the entrance of conduits that act as a molecular sieve, blocking conduit entry of large proteins. To determine whether PLVAP also regulates VACV entry into LN conduits, we injected Alexa Fluor 647-labeled VACV into the footpad of mice in which Plvap was conditionally deleted from LECs but remained intact on other cell types (Plvap fl/fl ; Prox1-CreERT tg/+ mice; ref. 29 ) ( Fig. 3d ). Conditional deletion of Plvap from LECs greatly increased the number of conduit-associated virions. Likewise, conditional deletion of Plvap enhanced the number of infected cells in the T cell zone 8 h after infection ( Fig. 3e ). Taken together, these data indicate that VACV virions can be accommodated by nodal conduits if the virions can enter and that many virions are normally excluded from conduit entry by PLVAP present on LECs.
VACV infects conduit-associated paracortical DCs. Immature DCs are located in close proximity to LN conduits and can acquire small proteins from the conduit lumen for presentation to T cells 3 .
Because immature DCs are susceptible to VACV infection ex vivo, we next sought to determine whether conduit-associated DCs could acquire VACV virions. Thus, we performed multiplex staining and confocal microscopy on LN sections collected 8 h after footpad injection with 10 8 PFU of VACV, allowing the identification of CD8α + CD205 + cDC1s and CD11b + cDC2s ( Fig. 4 ). As previously described, a majority of VACV-infected cells were sinus-resident macrophages 9,10 ( Fig. 4e) ; however, infected cDC1s and cDC2s could also be found associated with lymphatic sinuses (Fig. 4b,c ). In the paracortex, we identified infected cDC1s associated with conduits ( Fig. 4d ). Staining for individual markers ( Supplementary Fig. 5 ) corroborated the findings with multiplex staining. These data show that conduit-associated cDC1s in the T cell zone are infected by VACV.
Conduits transport ZIKV virions.
To determine whether other viruses could also enter LN conduits, we next performed similar imaging experiments after infection with ZIKV, a small RNA virus with a virion diameter of approximately 50 nm 30 . We infected Ifnar1 -/mice (a standard model of ZIKV infection) with 10 4 focus forming units (FFU) of ZIKV H/PF/2013 in the footpad and collected the popliteal LN 24 h after infection ( Fig. 5 ). Confocal imaging revealed ZIKV-infected cells in the LN paracortex ( Fig. 5a ), although it should be noted that, at this time point after infection, the presence of infected cells in this region could result from infection within the LN or migration from tissue. Multicolor staining for DC subsets (Fig. 5b ) revealed ZIKV-infected cDC1s ( Fig. 5d ) and cDC2s ( Fig. 5c ). Because CD205 + cDC1s are LN-resident, conduitassociated cells, this observation suggests that conduits could transport ZIKV virions. We next performed EM analysis on LNs from ZIKV-infected mice, imaging numerous instances of ZIKV virions in LN conduits ( Fig. 5e and Supplementary Fig. 6 ). Thus, like VACV, ZIKV can enter the nodal conduits and conduit-associated ZIKV-infected DCs can be identified in the LN paracortex. These data demonstrate that conduit transport is not a unique feature of VACV and can occur at much lower viral doses.
T cells are rapidly activated by paracortical VACV-infected cells.
VACV-specific CD8 + T cells are rapidly activated via direct priming in the peripheral interfollicular areas of the LN under a low virus dose 10 . To determine how T cell priming proceeds when virusinfected cells are present in both the LN periphery and the paracortex, we examined the location of T cell clusters around infected cells, an often-used indicator of cognate antigen presentation in imaging studies. Before infection, we transferred 10 6 OT-I CD8 + T cells (T cell receptor (TCR)-transgenic cells that are specific for H-2 K b -SIINFEKL 31 ) into recipient mice and infected them with VACV either expressing or lacking SIINFEKL ( Fig. 6 ). OT-I CD8 + T cells could be observed clustering around conduit-associated VACV-infected cells (an example near a high endothelial venule (HEV) is shown in Fig. 6a ).
As naive T cells enter through paracortical HEVs, we next queried whether the presence of infected cells in this nodal region yielded a temporal advantage for CD8 + T cell activation. Again, we transferred 10 6 dsRed + OT-I CD8 + T cells into mice and analyzed dissociated LNs by flow cytometry 8 h after infection ( Fig. 6b ). Approximately 70% of the transferred cells upregulated the activation marker CD69 at the highest dose of virus, whereas only 
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20% of T cells were activated with even a tenfold lower amount of virus. By 24 h after infection, all doses of virus greater than 10 5 PFU equally activated OT-I CD8 + T cells; however, when the inoculum was 10 5 PFU, there was a slight decrease in CD69 expression ( Fig. 6c ). Thus, sufficient antigen was present in the node at 10 6 PFU to activate all transferred T cells, yet T cells were activated most rapidly at the dose of virus yielding the most paracortical virus-infected cells. After infection with 10 8 PFU of VACV or MVA, a majority of virus-infected cells in the paracortex were contacted by OT-I CD8 + T cells, whereas there was a far lower percentage of infected cells in the SCS and IFA region that were contacted (Fig. 6d ). This observation suggests that paracortical infected cells are preferentially contacted by T cells, either because of a functional advantage or simply owing to ease of access.
We next quantified the mean fluorescence intensity (MFI) for CD69 on OT-I CD8 + T cells in sections of LNs collected 8 h after infection with 10 8 PFU of VACV (Fig. 6e-h and Supplementary  Fig. 7 ). OT-I CD8 + T cells in clusters around infected cells expressed abundant CD69 that was detectable by microscopy ( Fig. 6g) . We quantified the percentage of activated T cells (MFI ≥50) in each region of the LN at 10 8 PFU in ten LN sections ( Fig. 6e ). Approximately 40% of all nodal T cells were activated in the T cell zone, whereas less than 20% were activated in the SCS and IFA region. Accordingly, ~54% of activated T cells were in the paracortex (Fig. 6f ). In contrast, infection with lower viral doses resulted in the presence of activated cells primarily in the SCS and IFA region ( Supplementary Fig. 8 ). Next, we analyzed the CD69 MFI only on activated OT-I CD8 + T cells (MFI ≥50) across a single node ( Fig. 6h and Supplementary Fig. 7) . The MFI of activated T cells in the paracortex was significantly higher than in those at the periphery (average of 105 versus 89, respectively). Similarly to transgenic T cells, activated endogenous polyclonal CD8 + T cells also predominated in the T cell zone (Fig. 6i,j) . Collectively, these data show that VACV-infected cells in the T cell zone more rapidly activate CD8 + T cells than those in other nodal regions.
Lower VACV doses activate T cells in the LN paracortex.
To determine whether conduit transport also results in T cell activation after infection with lower VACV doses, we imaged LNs collected 8 h after infection with 10 6 PFU of VACV ( Fig. 7) . As expected, most infected cells were located in the SCS and IFA region ( Supplementary Fig. 8 ); however, we detected one or more paracortical, conduit-associated VACV-infected cells in most LN sections (Fig. 7a ). We next transferred 10 6 dsRed + OT-I CD8 + T cells into recipient mice, infected them with 10 6 PFU of VACV, and collected LNs 8 h later (Fig. 7b ). Although the majority of activated OT-I CD8 + T cells were present in the SCS and IFA region, we also detected T cell clustering and upregulation of CD69 around paracortical infected cells. Confocal analyses of DC subsets (as in Fig. 4 ) revealed that cDC1s in the paracortex could also be infected at lower VACV doses (Fig. 7c) . These data show that conduit transport of VACV for T cell activation also occurs at lower viral doses, albeit with greatly reduced frequency.
T cells have a temporal trafficking advantage. We next transferred OT-I CD8 + T cells into recipient mice and injected the footpad with different doses of VACV expressing SIINFEKL (Fig. 8 ). Twentyfour hours after footpad infection, we performed infection in the ear pinna with VACV lacking SIINFEKL (we have previously shown that this infection schedule results in antigen-independent recruitment of activated T cells to the skin but eliminates the possibility of T cell activation in the draining LN of the ear 32 ). Four days after footpad infection, we removed ears and analyzed the number of recruited T cells by flow cytometry (Fig. 8a ). After infection with 10 8 PFU of VACV, we detected significantly higher numbers of OT-I CD8 + T cells in the skin compared with lower doses, suggesting that footpad infection with the highest dose of virus leads to a temporal advantage in trafficking to infected peripheral tissue. Likewise, after footpad infection followed by skin infection with VACV expressing SIINFEKL, we detected higher numbers of IFN-γ-producing T cells in the skin directly ex vivo (without restimulation) at the highest virus dose compared with lower virus doses (Fig. 8b) . Thus, infection with the highest viral dose results in a temporal advantage for peripheral effector cell recruitment, consistent with early activation in LN paracortex.
Discussion
Our data provide evidence that virions can enter and move through LN conduits, infecting paracortical DCs that rapidly activate antiviral CD8 + T cells. Former studies examining conduit transport of antigen reproducibly demonstrated that the bulk of large-molecular-weight proteins and dextrans are excluded from conduit entry, suggesting a limited role for conduits in the delivery of large, complex antigens such as viruses to the LN paracortex 1,3,6-8 . Collectively, these studies utilized fluorescently labeled proteins or dextrans that could be detected by confocal microscopy as they filled the conduits. In these systems, very small numbers of proteins or dextrans entering the conduits would not be easily detectable by fluorescence and would not be likely to yield enough antigen to activate paracortical T cells. In contrast, cellular infection with a single VACV virion rapidly generates sufficient levels of viral peptide-MHC complexes for T cell activation and translation of many copies of viral proteins allows the detection of single infection events within 4 h. Thus, viruses serve as the perfect tool to uncover a previously unappreciated aspect of conduit function.
In ex vivo studies, paracortical cDC1s had a high capacity for priming antiviral CD8 + T cells 33, 34 , yet these cells are primarily positioned in the paracortex 5, 35 . Without nodal viral replication, it is unclear how these paracortical cDC1s can rapidly respond to infection, as most should not have access to virus in sinuses. For protein antigens, the location of MHC class I-specialized DCs in areas with limited antigen delivery substantially hinders the CD8 + T cell response in comparison to that of CD4 + T cells 7 . Virion transport by conduits has the potential to overcome these problems by delivering infectious virions to paracortical DCs.
The role of FRCs in the LN extends beyond forming the conduits. Indeed, FRC function is critical for normal immunological health during both homeostasis and infection. In uninfected LNs, FRCs produce cytokines and chemokines that attract and maintain DCs, naive T cells, and B cells [36] [37] [38] . FRCs provide a scaffold necessary for cellular motility and establish LN anatomical subregions, including the B cell follicles 39 . FRCs also control rapid LN expansion during infection and inflammation, proliferating and stretching to accommodate LN hypertrophy [40] [41] [42] . Because of the myriad FRC functions, any perturbation of the conduit network can dramatically impact the immune response.
Some viruses target the LN FRC network either directly or indirectly. LNs undergo marked fibrosis during HIV and simian immunodeficiency virus (SIV) infection during which collagen replaces the FRC network, which can no longer provide IL-7 to T cells, leading to T cell depletion 42, 43 . FRCs are directly infected by the murine pathogen lymphocytic choriomeningitis virus (LCMV), which results in upregulation of PD-L1, thereby slowing viral clearance 44 . Effector CD8 + T cells also eliminate LCMV-infected FRCs, limiting the immune response to new antigens 45, 46 . A number of other viruses also directly infect the FRC network, including Ebola, Marburg, and Lassa, and infected FRCs may propagate infectious virus, leading to complete destruction of lymphoid tissues [47] [48] [49] [50] . Our data suggest that infection by FRC-tropic viruses may be hastened after conduit transport of virions into the paracortex through increased pathogen accessibility to downstream, uninfected FRCs. However, in contrast to the aforementioned viruses, VACV and ZIKV do not robustly infect FRCs. The rapid appearance of VACV virions in the conduits (within 3 min of footpad infection) indicates that virions can access the conduits in the absence of FRC infection.
Although FRCs are not robustly infected by VACV, nodal infection results in LN hypertrophy and remodeling of the FRC conduits. In seminal studies, Gretz et al. demonstrated that VACV-induced LN hypertrophy did not disrupt the size exclusion of the conduit system 1 . To demonstrate maintenance of size exclusion during infection, small (10-kDa) and large (70-kDa) fluorescent dextrans were co-injected 8 h after infection with 10 7 PFU of VACV. Even though LNs had swelled and were ~40% larger than their original size, the pattern of tracer distribution in the LN remained unchanged. Thus, virus-induced conduit remodeling was unlikely to account for the presence of virions in the conduits within 8 h of infection, and conduit remodeling was even less likely during our EM studies, which were performed in LNs collected 3-5 min after infection. Because we observed both VACV and ZIKV virions within conduits, it seems improbable that a specific or single viral surface protein mediates access to the conduits. Future studies will determine the extent to which conduit entry is an active process exploited by viruses rather than simply being a general feature of conduit biology.
How do virions gain entry to the conduits? The endothelial protein PLVAP was recently shown to form a structure acting as a 'sieve' , allowing only low-molecular-weight proteins to enter the conduits 6 . Importantly, conditional deletion of Plvap afforded conduit entry to proteins ten times larger than the originally described 70-kDa size-exclusion limit, suggesting that virions could also 'fit' within the conduits if they gained access. Consistent with these studies, we show that conditional deletion of Plvap specifically in LECs also allows much larger numbers of virions to enter the conduits.
The simplest explanation for entry is that the LEC PLVAP sieve is leaky, allowing a few virions to pass through, especially when they are present at high concentration. As detailed ultrastructural studies of the LN mapping all conduit entry points have not been performed, it is unknown whether the structures made by PLVAP guard all or only a subset of LN conduits. Likewise, it remains possible that a limited number of sinus-borne virions could gain access to the conduit system, bypassing PLVAP. Evolutionarily, allowing a few virions to circumvent the sieve might make sense, as this would allow for rapid paracortical T cell priming without the risk of large-scale pathogen escape or complete paracortical infection. Recent studies have demonstrated that larger molecules (still much smaller than virions) can be accommodated by the conduit system if injected directly into the paracortex of the LN 8 . Thus, the ratelimiting step for virion transport is likely conduit entry, and it will be important to determine the mechanisms underlying access.
In summary, our study demonstrates the delivery of virions to the LN paracortex by conduits. This newly uncovered route of nodal antigen transport should prove informative for vaccine design, in particular for live viral or complexed-mRNA vaccines that can replicate small numbers of conduit-delivered antigen in paracortical APCs.
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Any methods, additional references, Nature Research reporting summaries, source data, statements of data availability and associated accession codes are available at https://doi.org/10.1038/ s41590-019-0342-0. with secondary antibodies as needed and as controls, and images were acquired using identical PMT (photomultiplier tube) and laser settings. In some instances, Huygens Essentials was used to deconvolve confocal images.
Confocal tile scans. Scans were taken of an entire popliteal LN section equivalent to a 7 mm 2 imaged area and individual fields (tiles) were merged into one image.
Image analysis.
Images were analyzed by using Imaris software (Bitplane). LN regions (SCS&IFA, T cell zone, medulla, and B cell follicles) were classified using Lyve-1, B220, and ERTR7 staining as described in ref. 18 . GFP + infected cells and OT-I CD8 + T cells were identified by using the spot detection algorithm of Imaris and were manually assigned to LN regions.
For analyses of infected cells touching conduits or sinuses, images were processed with Imaris software and a 2D projection of the LN slices was exported from this software for further analysis with CellProfiler, an open-source software package available from the Broad Institute at http://www.cellprofiler.org/. Image analysis then relied on separation of fluorescent channels between ERTR7 + (conduit and sinus) and Lyve-1 + (sinus) tissues versus GFP + (virus-infected) cells. Classification of these structures was achieved by using an Otsu thresholding algorithm with two classes. In each image, objects (either cells or tissue structures) were then identified by using CellProfiler-provided functions and infected cells (containing nuclearly localized fluorescence due to the karyophilic properties of the GFP fusion protein expressed 10 ) identified within ten microns of conduits or sinuses were classified as neighbors of one, both, or neither signal. This method of analysis was verified through by-hand counting of four LN tile scans by two separate individuals, with a strong correlation (R 2 = 0.948) between the computeridentified virus count and the by-hand-identified virus count.
For T cell activation analysis on LN sections, tile scans were taken for nodes stained for ERTR7, B220, and CD69 (polyclonal antibody) as described above. For calculation of the percentage of activated OT-I CD8 + T cells, dsRed OT-I cells were detected by using the spot algorithm of Imaris and the MFI of the CD69 channel was determined for each individual spot. Spots with an MFI of 50 or greater were considered to be activated T cells and were used to calculate the total percentage activated. Spots were then filtered to exclude those with MFI <50 and manually assigned an LN region. Where indicated, exclusion of non-activated cells was not performed (all T cells are shown).
Electron microscopy of LN sections.
Popliteal LNs were fixed in 2% glutaraldehyde in 0.1 M sodium cacodylate buffer (pH 7.2), washed in 0.1 M sodium cacodylate buffer, postfixed with 1% osmium tetroxide, and washed in buffer. Nodes were then incubated in 1% aqueous tannic acid, washed in sterile distilled water, and incubated with 2% aqueous uranyl acetate overnight and washed in water the next morning. Samples were dehydrated in an ethyl alcohol series (50%, 70%, 90%, 100%) and then with propylene oxide. Nodes were embedded in Embed 812 and sections were cut on a Leica EM UC7 ultramicrotome (Leica Microsystems). Thin sections were poststained with 7% uranyl acetate in 50% ethanol and then with 0.01% lead citrate. Sections were reviewed for conduits in the paracortex of the LN and identified conduits were scanned for the presence of virions. Identified virions were photographed on a Tecnai G2 Spirit transmission electron microscope (FEI/Thermo Fisher Scientific) fitted with a Gatan Orius CCD camera (Gatan) and an FEI Eagle camera. Chemicals were purchased from Electron Microscopy Sciences.
Statistical analyses.
Significance was calculated using GraphPad (Prism) by using unpaired two-tailed Student's t tests.
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